Maintenance Romidepsin (Rom) after Allogeneic Stem Cell Transplantation (Allo-SCT) in Aggressive T-Cell Malignancies Induces Long-Term Remissions and Enhances NK-Cell Cytotoxicity

2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR(2021)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要